Presentation is loading. Please wait.

Presentation is loading. Please wait.

Incidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesions  Tomoharu Dohi,

Published byNieves Ponce Salazar Modified over 5 years ago

Similar presentations

Presentation on theme: "Incidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesions  Tomoharu Dohi,"— Presentation transcript:

1 Incidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesions  Tomoharu Dohi, MD, Osamu Iida, MD, Yoshimitsu Soga, MD, Keisuke Hirano, MD, Kenji Suzuki, MD, Mitsuyoshi Takahara, MD, Masaaki Uematsu, MD, PhD, Shinsuke Nanto, MD, PhD  Journal of Vascular Surgery  Volume 59, Issue 4, Pages e1 (April 2014) DOI: /j.jvs Copyright © 2014 Society for Vascular Surgery Terms and Conditions

2 Fig 1 Patient flow diagram. EVT, Endovascular treatment; FP, femoropopliteal. Journal of Vascular Surgery  , e1DOI: ( /j.jvs ) Copyright © 2014 Society for Vascular Surgery Terms and Conditions

3 Fig 2 Cumulative 5-year rate of in-stent occlusion in 2447 limbs after femoropopliteal stenting with self-expanding nitinol stents. The cumulative rate of in-stent occlusion is depicted as a Kaplan-Meier curve. SE, Standard error. Journal of Vascular Surgery  , e1DOI: ( /j.jvs ) Copyright © 2014 Society for Vascular Surgery Terms and Conditions

4 Fig 3 Outcomes after in-stent occlusion during the study period.
Journal of Vascular Surgery  , e1DOI: ( /j.jvs ) Copyright © 2014 Society for Vascular Surgery Terms and Conditions

5 Supplementary Fig (online only)
Cumulative 5-year rate of in-stent occlusion among stent manufacturers. A significant difference was observed only between SMART and Luminexx. Journal of Vascular Surgery  , e1DOI: ( /j.jvs ) Copyright © 2014 Society for Vascular Surgery Terms and Conditions

Download ppt "Incidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesions  Tomoharu Dohi,"

Similar presentations

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Multidisciplinary care improves amputation-free survival in patients with chronic critical limb ischemia  Jayer Chung, MD, J. Gregory Modrall, MD, Chul.

Multidisciplinary care improves amputation-free survival in patients with chronic critical limb ischemia  Jayer Chung, MD, J. Gregory Modrall, MD, Chul.
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Min-Woong Sohn, PhD, Judith L. Meadows, MD, Elissa H

Min-Woong Sohn, PhD, Judith L. Meadows, MD, Elissa H
Age-related trends in utilization and outcome of open and endovascular repair for abdominal aortic aneurysm in the United States, 2001-2006  Margaret.

Age-related trends in utilization and outcome of open and endovascular repair for abdominal aortic aneurysm in the United States,   Margaret.
Stenting of femoropopliteal lesions using interwoven nitinol stents

Stenting of femoropopliteal lesions using interwoven nitinol stents
Results of endovascular repair of infrarenal aortic aneurysms using the Endurant stent graft  Herman J.A. Zandvoort, MD, PhD, Frederico Bastos Gonçalves,

Results of endovascular repair of infrarenal aortic aneurysms using the Endurant stent graft  Herman J.A. Zandvoort, MD, PhD, Frederico Bastos Gonçalves,
Endovascular repair of abdominal aortic aneurysm in octogenarians: An analysis based on EUROSTAR data  Conrad Lange, MD, Lina J. Leurs, MSc, Jaap Buth,

Endovascular repair of abdominal aortic aneurysm in octogenarians: An analysis based on EUROSTAR data  Conrad Lange, MD, Lina J. Leurs, MSc, Jaap Buth,
Jack R. W. Brownrigg, MBChB, Michelle Griffin, MBChB, Cian O

Jack R. W. Brownrigg, MBChB, Michelle Griffin, MBChB, Cian O
Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010  Grant H. Skrepnek, PhD, David G. Armstrong,

Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010  Grant H. Skrepnek, PhD, David G. Armstrong,
Fifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvage  Caren Randon, MD, Bart Jacobs, MD, Frederik.

Fifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvage  Caren Randon, MD, Bart Jacobs, MD, Frederik.
A randomized phase II study of Xilonix, a targeted therapy against interleukin 1α, for the prevention of superficial femoral artery restenosis after percutaneous.

A randomized phase II study of Xilonix, a targeted therapy against interleukin 1α, for the prevention of superficial femoral artery restenosis after percutaneous.
Arne Gerhard Schwindt, MD, Giuseppe Panuccio, MD, Konstantinos P

Arne Gerhard Schwindt, MD, Giuseppe Panuccio, MD, Konstantinos P
Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,
Lowell S. Kabnick, MD  Journal of Vascular Surgery 

Lowell S. Kabnick, MD  Journal of Vascular Surgery 
Clinical presentation, comorbidities, and age but not female gender predict survival after endovascular repair of abdominal aortic aneurysm  Peter Gloviczki,

Clinical presentation, comorbidities, and age but not female gender predict survival after endovascular repair of abdominal aortic aneurysm  Peter Gloviczki,
Blake A. Hamby, MD, Daniel E. Ramirez, MD, George E

Blake A. Hamby, MD, Daniel E. Ramirez, MD, George E
Endovascular abdominal aortic aneurysm repair: Long-term outcome measures in patients at high-risk for open surgery  Gregorio A. Sicard, MD, Robert M.

Endovascular abdominal aortic aneurysm repair: Long-term outcome measures in patients at high-risk for open surgery  Gregorio A. Sicard, MD, Robert M.

Similar presentations

Ads by Google